Diaralia NDC 0220-9097

NDC codes

FDA NDC Directory

Product NDC (as listed)0220-9097Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00220-9097Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0220-9097-42	00220909742	2 TUBE in 1 BOX (0220-9097-42) / 80 PELLET in 1 TUBE (0220-9097-41)Marketed from May 9, 2022

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Diaralia
Generic name (nonproprietary): arsenic trioxide, cinchona officinalis bark, podophyllum
Active ingredients: Podophyllum — 9 [hp_C]/1Cinchona officinalis bark — 5 [hp_C]/1Arsenic trioxide — 9 [hp_C]/1
Dosage form: Pellet
Route: Oral
Labeler: Boiron
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: May 9, 2022
Listing expires: Dec 31, 2026
Identifiers: Product ID 0220-9097_06ea4068-372b-527c-e063-6394a90ac081SPL ID 06ea4068-372b-527c-e063-6394a90ac081SPL set ID de968319-b5c1-3d31-e053-2995a90aa8a7UNII 2S713A4VP3, S003A158SB, S7V92P67HO

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400220909742 followed by a unit qualifier and the quantity

Package 00220-9097-42. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 4, 2023.

Indications (excerpt from the label)

Uses* temporarily relieves symptoms of diarrhea such as: traveler's diarrhea intestinal pain bloating gas nausea vomiting

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)